Episode Details

Mike Mussallem: In the Heart of OC Medtech

Ep. 8

The blossoming life sciences and medical device community in Orange County has shown incredible growth over the past few years. According to the 2019 California Life Science Association report, Orange County directly employed nearly 45,000 people in the life sciences industry, up 11% over the previous year. Of those, more than 23,000 were employed by medical device, instrument and diagnostic companies, which led the state. With Orange County being a microcosm for California as a whole, how do we continue to grow a collaborative atmosphere committed to supporting a productive medtech ecosystem?

In this episode of DeviceAlliance’s Medtech Radio, we interview Chairman and CEO of Edwards Lifesciences, Michael Mussallem. Under his leadership, Edwards has established its position as a global leader in patient-focused medical innovations with the introduction of lifesaving and life-sustaining therapies such as transcatheter aortic valve replacement, rapid-deployment surgical heart valve replacement and non-invasive hemodynamic monitoring. Join us as we speak with Mike about how Edwards plans to support Orange County's medical device community, and what we can do to drive collaboration, innovation, and career development for all device professionals in Southern California.

8

Follow the great work Mike and team are doing at Edwards Lifesciences.

Connect with Mike on LinkedIn

Thanks for listening! Please share our podcast on LinkedIn, Twitter, and Facebook, and stay tuned for our next episode!

OTHER MEDTECH RADIO EPISODES

  • All
  • Entrepreneurship/Startups
  • Leadership Spotlight
  • Marketing & Product Development
  • Professional Development
  • Women in MedTech
  • Young Professionals

Live DA Event: Critical Thinking on Clinical Trial Success | Ep.43

You’ve got a great idea for a medical device!  Now what? Most errors in clinical trials are a result of poor planning. Fancy statistical methods cannot rescue design flaws. Thus careful planning with clear foresight is absolutely crucial for clinical trial success.   With the explosion of Medtech opportunities for startups, what are the current